Jci_page_head_homepage_01 Jci_page_head_homepage_02
Alexandra Zanin-Zhorov, Liora Cahalon, Guy Tal, Raanan Margalit, Ofer Lider, Irun R. Cohen
Published in Volume 116, Issue 7
J Clin Invest. 2006; 116(7):2022–2032 doi:10.1172/JCI28423
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3
HSP60-treated CD4+ CD25+ T cells manifest augmented regulatory effects on CD4+ CD25 T cells.

(A) Bead-sorted CD4+CD25+ T cells (total), or FACS-sorted CD4+CD25hi (high) and CD4+CD25int (intermediate) T cells, were incubated with HSP60 (1 ng/ml) for 2 hours, washed, and cocultured with CD4+CD25 T cells (ratio 1:10) on anti-CD3 in serum-free medium. The supernatants were analyzed for IFN-γ and TNF-α. The means ± SD of 5 different donors are shown. (B) CD4+CD25+ T cells were incubated with HSP60 (1 ng/ml) for 2 hours, washed, mixed in the indicated proportions with CD4+CD25 T cells, and transferred to 96-well plates coated with anti-CD3 mAb (0.5 μg/ml or 5 μg/ml). Cell proliferation was determined after 96 hours. The means ± SD of 6 different donors are shown. *P < 0.05.